Review Note

Last Update: 03/02/2025 09:58 AM

Current Deck: ACG Part 2::Obstetrics

New Card (Unpublished)

Currently Published Content


Front
Back

No published tags.

Pending Suggestions


Field Change Suggestions:
SS_OB 1.16 Describe the pre-anaesthetic assessment of a pregnant woman
Importance:
  • Identify mothers at higher risk of complications during pregnancy and delivery
  • Minimise risk for patients by planning their care in advance (i.e. if assistance or tertiary care needed)
  • Improve patients experience by relieving anxiety and answering questions

Who should have an anaesthetic assessment?
  • All patients requiring anaesthetic intervention - GA or regional
  • If time does not permit a full assessment a brief assessment should be completed
When?
  • As early as possible - high risk patients should be seen between 30-34 weeks
  • Elective LSCS patients can be seen in the days preceding or DOS
  • If pregnant patient for non-obstetric surgery as early as possible for MDT planning

Pre-assessment:
  • History:
    • Obstetric Hx: Gravida, para, current gestation, intra-partum problems, past obstetric problems
    • PMHx
    • Medications
    • Allergies
    • Anaesthetic history
    • Fasting stats
    • GORD
    • Systems review, especially screening for co-existing disease e.g.cardiac, respiratory, obesity, endocrine (DM, thyroid), haematological (thrombosis, VTE, thrombophilia), neurological (spina bifida, myasthenia gravis, epilepsy, multiple sclerosis, tumour), MSK (Pre-existing back pain etc), psychiatric

  • Examination:
    • Vitals
    • BMI
    • CVS/Resp
    • Airway
    • Examination of spine
    • Fluid status/signs of haemorrhage
    • Signs of obstetric complications e.g.:
      • PET/eclampsia - GCS. clonus, liver tenderness, Papilloedema
      • GDM

  • Investigations
    • Bloods - FBC, esp Hb, plts, coags where relevant, G&H, U&E’s
    • Obstetric USS: Baby presenting part, placenta location

  • Consent:
    • Discuss anaesthetic intervention (GA, epidural, spinal, CSE), IV access, blood products and risks and benefits
Documentation - all of the above

Can use the modified WHO or CARPEG for risk predictions